Net 1 UEPS Technologies, Inc. to Host Conference Call to Review Second Quarter 2019 Results
JOHANNESBURG, South Africa, Jan. 16, 2019 (GLOBE NEWSWIRE) — Net 1 UEPS Technologies, Inc. (NasdaqGS: UEPS; JSE: NT1) (“Net1”) today […]
EFI to Report Fourth Quarter and Full Year 2018 Earnings Results on January 30, 2019
FREMONT, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) — Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing […]
Extraction Oil & Gas, Inc. Schedules Fourth-Quarter 2018 Earnings Release and Conference Call
DENVER, Jan. 16, 2019 (GLOBE NEWSWIRE) — Extraction Oil & Gas, Inc. (NASDAQ: XOG) will host a conference call on […]
VBI Vaccines Appoints Blaine McKee to Board of Directors
CAMBRIDGE, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) — VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation […]
Fibrocell to Present at Phacilitate Leaders World 2019
EXTON, Pa., Jan. 16, 2019 (GLOBE NEWSWIRE) — Fibrocell Science, Inc. (NASDAQ: FCSC), a gene therapy company focused on transformational […]
VirTra Reviews 2018 Operational Progress and Sets 2019 Strategic Priorities
Board of Directors Approves Increase of Company’s Share Repurchase Program to $2 Million TEMPE, Ariz., Jan. 16, 2019 (GLOBE NEWSWIRE) […]
Spirit of Texas Bancshares, Inc. Announces 2018 Fourth Quarter Earnings Release and Conference Call Schedule
CONROE, Texas, Jan. 16, 2019 (GLOBE NEWSWIRE) — Spirit of Texas Bancshares, Inc. (NASDAQ: STXB) (the “Company”), the bank holding […]
ToughBuilt Launches Sales with Menards® Home Improvement Chain
LAKE FOREST, Calif., Jan. 16, 2019 (GLOBE NEWSWIRE) — ToughBuilt Industries, Inc. (“ToughBuilt”) (NASDAQ: TBLT; TBLTW), a leading designer, manufacturer […]
CPS Technologies Corp. — Fourth Quarter Update
NORTON, Mass., Jan. 16, 2019 (GLOBE NEWSWIRE) — CPS Technologies Corporation (Nasdaq:CPSH) today announced that it expects revenues for the […]
Cue Biopharma Announces Presentation Highlighting Immuno-STAT Platform and CUE-101 at the 2019 Keystone Symposia Conference
Data Highlights the Potential of the CUE-100 Series to Selectively Deliver IL-2 to Tumor-relevant T cells while Mitigating the Risk […]
